의료 관련 주식
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 2490 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 9.24 USD | -3.65% | -18.59% | -22.48% | +115.89% | 736.95 M USD | ||
| 2512 |  SLDB Solid Biosciences Inc. - Common Stock | 7.19 USD | +9695.64% | +6.36% | +0.84% | +26.14% | 707.85 M USD | ||
| 2519 |  LMRI Lumexa Imaging Holdings, Inc. - Common Stock | 7.35 USD | -5.53% | -8.35% | -25.98% | -60.59% | 706.19 M USD | ||
| 2532 |  ANRO Alto Neuroscience, Inc. Common Stock | 19.81 USD | -1.54% | -6.78% | -20.63% | +661.92% | 695.21 M USD | ||
| 2536 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 0.09 USD | -99.05% | -98.95% | -98.92% | -99.05% | 6.85 M USD | ||
| 2546 |  ZVRA Zevra Therapeutics, Inc. - Common Stock | 11.49 USD | -0.86% | +13.20% | +13.65% | +7.99% | 679.23 M USD | ||
| 2565 |  CRMD CorMedix Inc. - Common Stock | 8.45 USD | +9911.85% | +4.71% | +9.03% | -25.22% | 662.92 M USD | ||
| 2569 |  BVS Bioventus Inc. - Class A Common Stock | 7.93 USD | -6.82% | -15.01% | -21.02% | +22.57% | 662.43 M USD | ||
| 2575 |  DSGN Design Therapeutics, Inc. - Common Stock | 10.47 USD | -0.10% | -4.73% | -22.16% | +176.98% | 653.92 M USD | ||
| 2584 |  TLRY Tilray Brands, Inc. - Common Stock | 5.49 USD | -0.36% | +0.73% | -10.73% | +1207.14% | 639.85 M USD | ||
| 2588 |  PHR Phreesia, Inc. Common Stock | 10.36 USD | +10428.46% | +15.75% | +7.14% | -55.78% | 640.37 M USD | ||
| 2591 |  CSTL Castle Biosciences, Inc. - Common stock | 20.97 USD | -0.52% | +4.22% | -15.20% | -14.79% | 636.02 M USD | ||
| 2594 |  SGP SpyGlass Pharma, Inc. - Common Stock | 0.18 USD | -4.88% | -99.14% | -99.25% | -99.25% | 6.12 M USD | ||
| 2595 |  SIBN SI-BONE, Inc. - Common Stock | 13.87 USD | -1.63% | -5.52% | +5.56% | -27.15% | 615.12 M USD | ||
| 2597 |  PRME Prime Medicine, Inc. - Common Stock | 3.40 USD | -4.23% | +12.96% | 0.00% | +188.14% | 614.10 M USD | ||
| 2598 |  DRUG Bright Minds Biosciences Inc. - common stock | 81.47 USD | -7.49% | -3.38% | -5.82% | +213.47% | 622.09 M USD | ||
| 2599 |  CADL Candel Therapeutics, Inc. - Common Stock | 8.49 USD | +2.29% | +4.43% | +29.62% | +55.49% | 622.06 M USD | ||
| 2618 |  PTCT PTC Therapeutics, Inc. - Common Stock | 73.80 USD | -0.07% | +7.17% | +13.40% | +50.58% | 612.17 M USD | ||
| 2619 |  EIKN Eikon Therapeutics, Inc. - Common Stock | 10.79 USD | -0.46% | -1.91% | +10.67% | -36.72% | 584.16 M USD | ||
| 2620 |  ACRS Aclaris Therapeutics, Inc. - Common Stock | 4.33 USD | -5.04% | -4.20% | -1.37% | +194.56% | 604.74 M USD |
뉴스 의료 관련 주식
Apogee Therapeutics, Inc. (APGE) Discusses Positive Part B Results From Phase 2 APEX Trial of Zumilokibart in Atopic Dermatitis Transcript
Top Analyst Reports for Microsoft, Dell & Thermo Fisher
Agios Pharmaceuticals, Inc. (AGIO) Discusses Global License Agreement for Cevidoplenib and Strategic Expansion in Rare Hematology Transcript
Top 25 High-Yield Dividend Stocks For June 2026
Is the Options Market Predicting a Spike in Prestige Consumer Stock?
Bausch + Lomb Corporation (BLCO) Discusses Project Halo and Myopia Control Developments in Vision Care - Slideshow (NYSE:BLCO) 2026-06-01
Immuneering Corporation (IMRX) Discusses Positive Atebimetinib ASCO Data Update in First-Line Pancreatic Cancer Transcript
Gainers 의료 관련 주식
 EWTX Edgewise Therapeutics, Inc. - Common Stock | 40.26 | +11685.71% |
 MBIO Mustang Bio, Inc. - Common Stock | 0.77 | +11392.54% |
 PMI Picard Medical, Inc. Common Stock | 0.17 | +11233.33% |
 HYPD Hyperion DeFi, Inc. - Common Stock | 3.86 | +10928.57% |
 CLYM Climb Bio, Inc. - Common Stock | 11.80 | +10666.42% |
 KPRX Kiora Pharmaceuticals, Inc. - Common Stock | 2.87 | +10608.96% |
 ADGM Adagio Medical Holdings, Inc - Common Stock | 0.77 | +10594.44% |
 ORIC Oric Pharmaceuticals, Inc. - Common Stock | 8.98 | +10527.22% |
